
Intra-tumor and inter-patient heterogeneity are two challenges in developing mathematical models for precision medicine diagnostics. Here we review several techniques that can be used to aid the mathematical modeller in inferring and quantifying both sources of heterogeneity from patient data. These techniques include virtual populations, nonlinear mixed effects modeling, non-parametric estimation, Bayesian techniques, and machine learning. We create simulated virtual populations in this study and then apply the four remaining methods to these datasets to highlight the strengths and weak-nesses of each technique. We provide all code used in this review at https://github.com/jtnardin/Tumor-Heterogeneity/ so that this study may serve as a tutorial for the mathematical modelling community. This review article was a product of a Tumor Heterogeneity Working Group as part of the 2018–2019 Program on Statistical, Mathematical, and Computational Methods for Precision Medicine which took place at the Statistical and Applied Mathematical Sciences Institute.
Citation: Rebecca Everett, Kevin B. Flores, Nick Henscheid, John Lagergren, Kamila Larripa, Ding Li, John T. Nardini, Phuong T. T. Nguyen, E. Bruce Pitman, Erica M. Rutter. A tutorial review of mathematical techniques for quantifying tumor heterogeneity[J]. Mathematical Biosciences and Engineering, 2020, 17(4): 3660-3709. doi: 10.3934/mbe.2020207
[1] | Jing Cai, Jianfeng Yang, Yongjin Zhang . Reliability analysis of s-out-of-k multicomponent stress-strength system with dependent strength elements based on copula function. Mathematical Biosciences and Engineering, 2023, 20(5): 9470-9488. doi: 10.3934/mbe.2023416 |
[2] | Amal S. Hassan, Najwan Alsadat, Christophe Chesneau, Ahmed W. Shawki . A novel weighted family of probability distributions with applications to world natural gas, oil, and gold reserves. Mathematical Biosciences and Engineering, 2023, 20(11): 19871-19911. doi: 10.3934/mbe.2023880 |
[3] | Ghada Mohammed Mansour, Haroon Mohamed Barakat, Islam Abdullah Husseiny, Magdy Nagy, Ahmed Hamdi Mansi, Metwally Alsayed Alawady . Measures of cumulative residual Tsallis entropy for concomitants of generalized order statistics based on the Morgenstern family with application to medical data. Mathematical Biosciences and Engineering, 2025, 22(6): 1572-1597. doi: 10.3934/mbe.2025058 |
[4] | Yarong Yu, Liang Wang, Sanku Dey, Jia Liu . Estimation of stress-strength reliability from unit-Burr Ⅲ distribution under records data. Mathematical Biosciences and Engineering, 2023, 20(7): 12360-12379. doi: 10.3934/mbe.2023550 |
[5] | Mahmoud El-Morshedy, Zubair Ahmad, Elsayed tag-Eldin, Zahra Almaspoor, Mohamed S. Eliwa, Zahoor Iqbal . A new statistical approach for modeling the bladder cancer and leukemia patients data sets: Case studies in the medical sector. Mathematical Biosciences and Engineering, 2022, 19(10): 10474-10492. doi: 10.3934/mbe.2022490 |
[6] | Thomas Hillen, Kevin J. Painter, Amanda C. Swan, Albert D. Murtha . Moments of von mises and fisher distributions and applications. Mathematical Biosciences and Engineering, 2017, 14(3): 673-694. doi: 10.3934/mbe.2017038 |
[7] | Mohamed Kayid . Some new results on bathtub-shaped hazard rate models. Mathematical Biosciences and Engineering, 2022, 19(2): 1239-1250. doi: 10.3934/mbe.2022057 |
[8] | Mohamed S. Eliwa, Buthaynah T. Alhumaidan, Raghad N. Alqefari . A discrete mixed distribution: Statistical and reliability properties with applications to model COVID-19 data in various countries. Mathematical Biosciences and Engineering, 2023, 20(5): 7859-7881. doi: 10.3934/mbe.2023340 |
[9] | Ibrahim Alkhairy . Classical and Bayesian inference for the discrete Poisson Ramos-Louzada distribution with application to COVID-19 data. Mathematical Biosciences and Engineering, 2023, 20(8): 14061-14080. doi: 10.3934/mbe.2023628 |
[10] | Ariel Cintrón-Arias, Carlos Castillo-Chávez, Luís M. A. Bettencourt, Alun L. Lloyd, H. T. Banks . The estimation of the effective reproductive number from disease outbreak data. Mathematical Biosciences and Engineering, 2009, 6(2): 261-282. doi: 10.3934/mbe.2009.6.261 |
Intra-tumor and inter-patient heterogeneity are two challenges in developing mathematical models for precision medicine diagnostics. Here we review several techniques that can be used to aid the mathematical modeller in inferring and quantifying both sources of heterogeneity from patient data. These techniques include virtual populations, nonlinear mixed effects modeling, non-parametric estimation, Bayesian techniques, and machine learning. We create simulated virtual populations in this study and then apply the four remaining methods to these datasets to highlight the strengths and weak-nesses of each technique. We provide all code used in this review at https://github.com/jtnardin/Tumor-Heterogeneity/ so that this study may serve as a tutorial for the mathematical modelling community. This review article was a product of a Tumor Heterogeneity Working Group as part of the 2018–2019 Program on Statistical, Mathematical, and Computational Methods for Precision Medicine which took place at the Statistical and Applied Mathematical Sciences Institute.
Tuberculosis (TB) is a common and fatal infectious disease. It has become a chronic infectious disease that threatens human health worldwide. Globally, in 2016 there were an estimated 10.4 million incident cases of TB, equivalent to 140 cases per 100000 population. Meanwhile, the proportion of people who develop TB and die from the disease (the case fatality ratio) was 16 [1]. Therefore, TB has become a global concern for social and public health issues.
Many scholars have carried out a lot of excellent researches on the transmission mechanism and prevention strategies of TB [2,3,4,5,6]. Silva et al. [4] introduced delays in a TB model, and studied optimal control of TB with state and control delays. Huo et al. [5] presented a two-strain TB model with general contact rate which allows TB patients with the drug sensitive of strain Mycobacterium tuberculosis to be treated and gave a detailed qualitative analysis about positivity, boundedness, existence, uniqueness and global stability of the equilibria of the model. Huo and Zou [6] studied a TB model with two kinds of treatment, that is, treatment at home and treatment in hospital and showed that the treatment at home has a negative influence on the spread of TB.
The susceptible individuals who carry the pathogen developing into infectious individuals are different from the progression of TB transmission. Some people may become symptomatic infectious individuals after a few days or months, and some people may occur after several years or even decades. For the former, it is considered that the susceptible individuals directly develop symptomatic infectious individuals without going through the latency period after infection, which is called the fast progression of TB transmission. For the latter, it is considered that the susceptible individuals become the latent individuals carrying the pathogen after infection with Mycobacterium tuberculosis, and they can become infected by exogenous reinfection or endogenous infection, which is called a slow progression of TB transmission. Huo and Feng [7] constructed an HIV/AIDS epidemic model with different latent stages and treatment. The model allowed for the latent individuals to have the fast and slow latent compartments. Mccluskey [8] introduced the spread of TB through two models which included fast and slow progression to the infected class. Berge et al. [9] considered a two patch cholera model with the aim of investigating the impact of human population movements between two cities(patches). Song et al. [10] studied TB models with fast and slow dynamics. Many scholars have studied infectious diseases related to the fast and slow progression (see e.g. [11] and references cited therein).
Media coverage is changing the way that we communicate with each other in our daily life, work and study. The media may be the most important source of public health information. At the same time, it also plays an important role in the spread and control of epidemics by providing some health information. Cui et al. [12] proposed a general contact rate β(I)=c1−c2f(I) to reflect some intrinsic characters of media coverage. Huo and Zhang [13] introduced a novel alcoholism model which involves impact of Twitter, and showed that Twitter can serve as a good indicator of alcoholism model and affect the spread of the drinking. Huo et al. [14] presented a SEIS epidemic model with the impact of media coverage. Their results manifested that media can be regarded as a good indicator in controlling the emergence and spread of the epidemic disease. Many scholars have done a lot of researches on infectious diseases with or without media coverage [15,16,17,18,19,20,21].
Motivated by the above, we construct a new TB model which not only involves fast and slow progression but also incorporates the impact of media coverage in this paper. We study the stability of all the equilibria. Furthermore, we also investigate the occurrence of backward and forward bifurcation. Our results show that media coverage can encourage people to take countermeasures to avoid potential infections.
The rest of this paper is organized as follows. In Section 2, a new tuberculosis model with fast and slow progression and media coverage is constructed. In Section 3, we discuss the existence and stability of all the equilibria, then we analyze a forward and backward bifurcation. Some numerical simulations are presented in Section 4. Sensitivity analysis and some discussions are given in the last section.
The total population N(t) is divided into four compartments: S(t), E(t), I(t) and R(t). S(t) denotes susceptible individuals. E(t) is referred to as undetected non-symptomatic (latent) carriers. I(t) is symptomatic infectious individuals. R(t) represents recovered individuals. M(t) represents the number of message that all of them provide about TB at time t. The total population N(t) is given by
N(t)=S(t)+E(t)+I(t)+R(t). |
The transfer diagram of the model is shown in Figure 1. The transfer diagram leads to the following system of ordinary differential equations:
{dS(t)dt=δ−βSIe−αM−μS,dE(t)dt=(1−q)βSIe−αM−(μ+ε)E,dI(t)dt=qβSIe−αM+εE−(d+μ+γ)I,dR(t)dt=γI−μR,dM(t)dt=μ1S+μ2E+μ3I+μ4R−τM. | (2.1) |
All the parameters are positive constants. δ is the constant recruitment rate of the population. β is the transmission coefficient of TB. α is the coefficient that determines how effective the disease-related messages can influence the transmission rate and the transmission rate β is reduced by a factor e−αM (see [13,14]). μ is the natural death rate. q is the proportion of disease by fast progression. ε is the progression rate from the exposed individuals to the infected individuals. d is the disease-related death rate of TB. γ is the recovery rate of TB. τ is the rate that message become outdated. μ1, μ2, μ3 and μ4 are the rates that susceptible individuals, exposed individuals, infectious individuals, recovered individuals may send messages about TB, respectively.
In this section, we will show positivity and boundedness for system (2.1).
Lemma 1. If S(0)≥0,E(0)≥0,I(0)≥0,R(0)≥0,M(0)≥0, the solutions S(t), E(t), I(t), R(t), M(t) of system (2.1) are positive for all t>0.
Proof. If S(0)≥0, according to the first equation of system (2.1), we have
dS(t)dt=δ−[βI(t)e−αM(t)+μ]S(t). |
It can be rewritten as:
dS(t)dtexp{∫t0[βI(u)e−αM(u)+μ]du}+S(t)[βI(t)e−αM(t)+μ]exp{∫t0[βI(u)e−αM(u)+μ]du}=δexp{∫t0[βI(u)e−αM(u)+μ]du}. |
Therefore,
ddt(S(t)exp{∫t0[βI(u)e−αM(u)+μ]du})=δexp{∫t0[βI(u)e−αM(u)+μ]du}. |
Hence,
S(t)exp{∫t0[βI(u)e−αM(u)+μ]du}−S(0)=∫t0(δexp{∫u0[βI(v)e−αM(v)+μ]dv})du. |
So,
S(t)=S(0)exp{−∫t0[βI(u)e−αM(u)+μ]du}+exp{−∫t0[βI(u)e−αM(u)+μ]du}{∫t0(δexp{∫u0[βI(v)e−αM(v)+μ]dv})du}>0. |
Similarly, we can show that E(t)>0,I(t)>0,R(t)>0,M(t)>0. So the solutions S(t), E(t), I(t), R(t), M(t) of system (2.1) with initial conditions S(0)≥0,E(0)≥0,I(0)≥0,R(0)≥0,M(0)≥0 are positive for all t>0. This completes the proof of Lemma 1.
Lemma 2. The feasible region Ω defined by
Ω={(S,E,I,R,M)∈R5+:0≤S+E+I+R≤δμ,0≤M≤δ(μ1+μ2+μ3+μ4)μτ} |
with initial conditions S(0)≥0,E(0)≥0,I(0)≥0,R(0)≥0,M(0)≥0 is positively invariant for system (2.1).
Proof. Adding the former four equations of system (2.1), we obtain
dN(t)dt=δ−μN(t)−dI(t)≤δ−μN(t). |
It follows that
0≤N(t)≤δμ+N(0)e−μt, |
where N(0) is the initial value of total number of people. Thus,
limt→∞supN(t)≤δμ. |
Then
0≤S(t)+E(t)+I(t)+R(t)≤δμ. |
Further, from the last equation of system (2.1), we have
dM(t)dt=μ1S(t)+μ2E(t)+μ3I(t)+μ4R(t)−τM(t)≤δμ(μ1+μ2+μ3+μ4)−τM(t). |
It follows that
0≤M(t)≤δ(μ1+μ2+μ3+μ4)μτ+M(0)e−τt, |
where M(0) represents the initial value of cumulative density media coverage. Thus,
limt→∞supM(t)≤δ(μ1+μ2+μ3+μ4)μτ. |
It implies that the region
Ω={(S,E,I,R,M)∈R5+:0≤S+E+I+R≤δμ,0≤M≤δ(μ1+μ2+μ3+μ4)μτ} |
is a positively invariant set for system (2.1). So we consider dynamics of system (2.1) on the set Ω in this paper. This completes the proof of Lemma 2.
It is easy to see system (2.1) always has a disease-free equilibrium
P0=(S0,E0,I0,R0,M0)=(δμ,0,0,0,μ1δμτ). | (3.1) |
We can obtain the basic reproductive number R0 by using the next-generation method [22]. Let x=(E,I,R,S,M)T, then system (2.1) can be written as
dxdt=F(x)−V(x), |
where,
F(x)=((1−q)βSIe−αMqβSIe−αM000)andV(x)=((μ+ε)E−εE+(d+μ+γ)I−γI+μR−δ+βSIe−αM+μS−μ1S−μ2E−μ3I−μ4R+τM). |
The Jacobian matrices of F(x) and V(x) at the disease-free equilibrium P0 are, respectively,
DF(P0)=(F3×300000000),DV(P0)=(V3×3000βδμe−αμ1δμτ0μ0−μ2−μ3−μ4−μ1τ), |
where
F=(0(1−q)βδμe−αμ1δμτ00qβδμe−αμ1δμτ0000),V=(μ+ε00−εd+μ+γ00−γμ). |
The basic reproductive number, denoted by R0 is thus given by
R0=ρ(FV−1)=(ε+μq)βδe−αμ1δμτμ(μ+ε)(d+μ+γ). | (3.2) |
Theorem 1. The disease-free equilibrium P0=(δμ,0,0,0,μ1δμτ) of system (2.1) is locally asymptotically stable if R0<1, and is unstable if R0>1.
Proof. The Jacobian matrix corresponding to system (2.1) about P0=(δμ,0,0,0,μ1δμτ) is obtained as follows:
J(P0)=(−μ0−βδμe−αμ1δμτ000−(μ+ε)(1−q)βδμe−αμ1δμτ000εqβδμe−αμ1δμτ−(d+μ+γ)0000γ−μ0μ1μ2μ3μ4−τ). |
The characteristic equation corresponding to the Jacobian matrix J(P0) is given by |λE−J(P0)|=0, where λ is the eigenvalue and E is the unit matrix. Thus, we get
(λ+τ)(λ+μ)2[λ2+(2μ+ε+d+γ−qβδμe−αμ1δμτ)λ+(μ+ε)(d+μ+γ)−βδ(ε+μq)μe−αμ1δμτ]=0. | (3.3) |
Obviously, Eq. (3.3) has three negative roots λ1=−τ, λ2=λ3=−μ, and the other two roots λ4 and λ5 are determined by
λ2+(2μ+ε+d+γ−qβδμe−αμ1δμτ)λ+(μ+ε)(d+μ+γ)−βδ(ε+μq)μe−αμ1δμτ=0. | (3.4) |
According to the above calculation and analysis, we can obtain
λ4λ5=(μ+ε)(d+μ+γ)−βδ(ε+μq)μe−αμ1δμτ=(μ+ε)(d+μ+γ)(1−R0), |
λ4+λ5=qβδμe−αμ1δμτ−(2μ+ε+d+γ)=(μ+ε)(d+μ+γ)qε+μq[(ε+μq)βδe−αμ1δμτμ(μ+ε)(d+μ+γ)−ε+μq(μ+ε)q−ε+μq(d+μ+γ)q]=(μ+ε)(d+μ+γ)qε+μq[R0−ε+μqεq+μq−ε+μq(d+μ+γ)q]<(μ+ε)(d+μ+γ)qε+μq[R0−1−ε+μq(d+μ+γ)q]. |
If R0<1, we have λ4λ5>0, λ4+λ5<0, hence λ4<0,λ5<0. Therefore, P0=(δμ,0,0,0,μ1δμτ) is locally asymptotically stable. If R0>1, Eq. (3.4) has two real roots that one is positive and another is negative. In this case, P0=(δμ,0,0,0,μ1δμτ) is unstable. This completes the proof of Theorem 1.
Theorem 2. The disease-free equilibrium P0=(δμ,0,0,0,μ1δμτ) of the system (2.1) is globally asymptotically stable if R0<1 and M(t)≥μ1δμτ.
Proof. Motivated by Huo and Zhang [13], we define the Lyapunov function
V(t)=εE(t)+(μ+ε)I(t). |
It is clear that V(t)≥0 and the equality holds if and only if E(t)=I(t)=0.
From the first equation of the system (2.1), we have
dSdt=δ−βSIe−αM−μS≤δ−μS, |
and then we can obtain S(t)≤δμ.
Differentiating V(t) with respect to time t yields:
dV(t)dt=εdE(t)dt+(μ+ε)dI(t)dt=βSIe−αM(ε+μq)−(μ+ε)(d+μ+γ)I≤βδ(ε+μq)e−αμ1δμτμI−(μ+ε)(d+μ+γ)I=(μ+ε)(d+μ+γ)I[βδ(ε+μq)e−αμ1δμτμ(μ+ε)(d+μ+γ)−1]=(μ+ε)(d+μ+γ)I(R0−1). |
It follows that V(t) is bounded and non-increasing. Therefore, limt→∞V(t) exists. Note that dV(t)dt=0 if and only if E=I=R=0,S=S0=δμ,M=M0=μ1δμτ. The maximum invariant set of the system (2.1) on the set {(S,E,I,R,M):dV(t)dt=0} is the singleton P0=(δμ,0,0,0,μ1δμτ). And note that R0<1 guarantees that dV(t)dt≤0 for all t≥0. By LaSalle's Invariance Principle [23], the disease-free equilibrium P0=(δμ,0,0,0,μ1δμτ) is globally asymptotically stable when R0<1 and M(t)≥μ1δμτ. This completes the proof of Theorem 2.
First, we introduce:
Φ=−αμτ(μq+ε){(μq+ε)(γμ4+μμ3)+(d+μ+γ)[μμ2(1−q)−μ1(μ+ε)]}, | (3.5) |
R01=δ(μq+ε)Φ(μ+ε)(d+μ+γ), | (3.6) |
Rc=R01e1−R01. | (3.7) |
Remark 1. It is clear to check that: R01>0 if and only if Φ>0; R01=0 if and only if Φ=0; R01<0 if and only if Φ<0.
Theorem 3. For system (2.1),
(ⅰ) If R0>max{1,R01}, there is a unique endemic equilibrium P∗1.
(ⅱ) If Rc=R0<min{1,R01} and R01>0, there is a unique endemic equilibrium P∗2.
(ⅲ) If Rc<R0<min{1,R01} and R01>0, there are two distinct endemic equilibria P∗3 and P∗4.
Proof. The endemic equilibrium P∗(S∗,E∗,I∗,R∗,M∗) of system (2.1) is determined by equations
{δ−βSIe−αM−μS=0,(1−q)βSIe−αM−(μ+ε)E=0,qβSIe−αM+εE−(d+μ+γ)I=0,γI−μR=0,μ1S+μ2E+μ3I+μ4R−τM=0. | (3.8) |
Further, we obtain
S=δμ−(μ+ε)(d+μ+γ)μ(μq+ε)I, | (3.9) |
E=(1−q)(d+μ+γ)μq+εI, | (3.10) |
R=γμI, | (3.11) |
M=μ1δμτ−ΦαI, | (3.12) |
where Φ is given by (3.5). Substituting S,M into the first equation of (3.8) yields
R0[1−(μ+ε)(d+μ+γ)δ(μq+ε)I]=e−ΦI. | (3.13) |
According to (3.6) and (3.13), we have
R0(1−ΦR01I)−e−ΦI=0. |
We consider a function F(I) defined by
F(I)=R0(1−ΦR01I)−e−ΦI. | (3.14) |
Then, we have
F(0)=R0−1,F(+∞)=−∞, |
F′(I)=−R0R01Φ+Φe−ΦI,F′(0)=−R0R01Φ+Φ, |
F″(I)=−Φ2e−ΦI. |
Case 1. When Φ=0, according to (3.13), we have
I=δ(μq+ε)(μ+ε)(d+μ+γ)(1−1R0). |
Therefore, there is a unique endemic equilibrium if Φ=0 and R0>1.
Case 2. When Φ≠0, we have
F″(I)=−Φ2e−ΦI<0. |
Thus, we get F′(I)<F′(0), which means Φe−ΦI<Φ.
(1) If R0>1, we have F(0)=R0−1>0, F(+∞)=−∞<0, and
F′(I)=−R0R01Φ+Φe−ΦI<−R0R01Φ+Φ=(1−R0R01)Φ. |
When R0>R01>0, we have Φ>0 and 1−R0R01<0, which means F′(I)<0.
When R0>0>R01, we have Φ<0 and 1−R0R01>0, which means F′(I)<0.
Therefore, there is a unique endemic equilibrium if Φ≠0 and R0>max{1,R01}.
In conclusion, there is a unique endemic equilibrium P∗1 if R0>max{1,R01}.
(2) If R0<1, we have F(0)=R0−1<0, F(+∞)=−∞<0, Let's suppose
F′(I)=−R0R01Φ+Φe−ΦI=0. |
Then we obtain
Ic=1ΦlnR01R0. |
When R0<R01, we have Φ>0 and lnR01R0>0, which means Ic>0.
Substituting Ic into (3.14), we get
F(Ic)=R0+R0R01(lnR0R01−1). |
(a) When F(Ic)=0, we can obtain I∗2=Ic and R0=Rc, where Rc is given by (3.7).
Therefore, there is a unique endemic equilibrium P∗2 if Rc=R0<min{1,R01} and R01>0.
(b) When F(Ic)>0, we can obtain R0>Rc.
Since F(0)=R0−1<0, F(+∞)=−∞<0 and F(Ic)>0, we know that F(I)=0 has two different positive solutions I∗3 and I∗4. Let I∗3 and I∗4 satisfy I∗3<I∗2<I∗4. Therefore, there are two distinct endemic equilibria P∗3 and P∗4 if Rc<R0<min{1,R01} and R01>0. This completes the proof of Theorem 3.
Theorem 4. When q=0, the endemic equilibria P∗i(i=1,2,3,4) of system (2.1) have the following qualities:
(ⅰ) If R0>max{1,R01}, a1(I∗1)a2(I∗1)−a3(I∗1)>0, a3(I∗1)[a1(I∗1)a2(I∗1)−a3(I∗1)]−[a1(I∗1)]2a4(I∗1)>0 and a4(I∗1)>0, the endemic equilibrium P∗1 is locally asymptotically stable.
(ⅱ) If Rc=R0<min{1,R01} and R01>0, the endemic equilibrium P∗2 is unstable.
(ⅲ) If Rc<R0<min{1,R01} and R01>0, the endemic equilibrium P∗3 is unstable.
(ⅳ) If Rc<R0<min{1,R01} and R01>0, the stability of the endemic equilibrium P∗4 is uncertain.
Proof. When q=0, the Jacobian matrix corresponding to system (2.1) about P∗i(i=1,2,3,4) are obtained as follows:
J(P∗i)=(−βI∗ie−αM∗i−μ0−βS∗ie−αM∗i0αβS∗iI∗ie−αM∗iβI∗ie−αM∗i−(μ+ε)βS∗ie−αM∗i0−αβS∗iI∗ie−αM∗i0ε−(d+μ+γ)0000γ−μ0μ1μ2μ3μ4−τ). |
The characteristic equation corresponding to the Jacobian matrix J(P∗i) is given by |λE−J(P∗i)|=0, where λ is the eigenvalue and E is the unit matrix. Thus, we get
|λ+βI∗ie−αM∗i+μ0βS∗ie−αM∗i0−αβS∗iI∗ie−αM∗i−βI∗ie−αM∗iλ+μ+ε−βS∗ie−αM∗i0αβS∗iI∗ie−αM∗i0−ελ+d+μ+γ0000−γλ+μ0−μ1−μ2−μ3−μ4λ+τ|=0. |
We set Θ=βe−αM∗i, then
Θ=βe−αμ1δμτeΦI∗i=μ(μ+ε)(d+μ+γ)eΦI∗iR0εδ=μΦeΦI∗iR0R01. |
From the second equation of (3.8), we have
βS∗iI∗ie−αM∗i=(μ+ε)E∗i=(μ+ε)(d+μ+γ)εI∗i, |
then
ΘS∗i=βS∗ie−αM∗i=(μ+ε)(d+μ+γ)ε=δΦR01, |
and
ΘS∗iI∗i=βS∗iI∗ie−αM∗i=(μ+ε)(d+μ+γ)εI∗i=δΦR01I∗i. |
Therefore, the characteristic equation can be rewritten as:
(λ+μ)F(λ)=0, | (3.15) |
where
F(λ)=λ4+a1(I∗i)λ3+a2(I∗i)λ2+a3(I∗i)λ+a4(I∗i), | (3.16) |
where
a1(I∗i)=d+γ+3μ+ε+τ+ΘI∗i, | (3.17) |
a2(I∗i)=(d+γ+2μ+ε+τ)(μ+ΘI∗i)+τ(d+γ+2μ+ε)+αδΦR01I∗i(μ2−μ1), | (3.18) |
a3(I∗i)=μΘI∗i(d+γ+2τ+ε+μ)+τ(ε+d+γ)(μ+ΘI∗i)+ε(d+γ)ΘI∗i |
+αδΦR01I∗i[(d+γ+2μ)(μ2−μ1)+ε(μ3−μ1)], | (3.19) |
a4(I∗i)=τ(μ+ε)(d+γ+μ)[(μ+ΘI∗i)−μ(1+ΦI∗i)]. | (3.20) |
(ⅰ) According to (3.17)-(3.20), we have
a1(I∗1)=d+γ+3μ+ε+τ+ΘI∗1,a2(I∗1)=(d+γ+2μ+ε+τ)(μ+ΘI∗1)+τ(d+γ+2μ+ε)+αδΦR01I∗1(μ2−μ1),a3(I∗1)=μΘI∗1(d+γ+2τ+ε+μ)+τ(ε+d+γ)(μ+ΘI∗1)+ε(d+γ)ΘI∗1+αδΦR01I∗1[(d+γ+2μ)(μ2−μ1)+ε(μ3−μ1)],a4(I∗1)=τ(μ+ε)(d+γ+μ)[(μ+ΘI∗1)−μ(1+ΦI∗1)]. |
It is clear that a1(I∗1)>0, according to Routh−Hurwitz criteria [24], the proof (ⅰ) of Theorem 4 is obtained.
(ⅱ) According to the proof of (ⅱ) of Theorem 3, we have I∗2=1ΦlnR01R0. Then, we can get ΘI∗2=μΦI∗2. Therefore, based on (3.17)-(3.20), we can obtain
a1(I∗2)=d+γ+3μ+ε+τ+ΘI∗2>0,a4(I∗2)=τμ(μ+ε)(d+γ+μ)[(1+ΦI∗2)−(1+ΦI∗2)]=0. |
It is easy to know that a3(I∗2)≠0, and a1(I∗2)a2(I∗2)−a3(I∗2)<0. Therefore, we know that Eq. (3.15) has negative, positive and zero eigenvalues. So the endemic equilibrium P∗2 of system (2.1) is unstable.
(ⅲ) Due to I∗3<I∗2=1ΦlnR01R0, we can get ΘI∗3<μΦI∗3. Therefore, based on (3.17)-(3.20), we can obtain
a1(I∗3)=d+γ+3μ+ε+τ+ΘI∗3>0, |
and
a4(I∗3)<τμ(μ+ε)(d+γ+μ)[(1+ΦI∗3)−(1+ΦI∗3)]=0. |
Let gj(I∗3)(j=1,2,3,4) be the solutions of F(λ)=0, and we assume that the real parts satisfy Re(g1(I∗3))≤Re(g2(I∗3))≤Re(g3(I∗3))≤Re(g4(I∗3)), where Re means the real part of a complex number. Then we can obtain gj(I∗3)(j=1,2,3,4) satisfying
g1(I∗3)+g2(I∗3)+g3(I∗3)+g4(I∗3)=−a1(I∗3)<0, |
and
g1(I∗3)g2(I∗3)g3(I∗3)g4(I∗3)=a4(I∗3)<0. |
So, we have Re(g1(I∗3))<0 and Re(g4(I∗3))>0. Then, we know that the endemic equilibrium P∗3 of system (2.1) is unstable.
(ⅳ) Due to I∗4>I∗2=1ΦlnR01R0, we have ΘI∗4>μΦI∗4. Therefore, based on (3.17)-(3.20), we can obtain
a1(I∗4)=d+γ+3μ+ε+τ+ΘI∗4>0 |
and
a4(I∗4)>τμ(μ+ε)(d+γ+μ)[(1+ΦI∗4)−(1+ΦI∗4)]=0. |
Let gj(I∗4)(j=1,2,3,4) be the solutions of F(λ)=0, and we assume that the real parts satisfy Re(g1(I∗4))≤Re(g2(I∗4))≤Re(g3(I∗4))≤Re(g4(I∗4)). Then we can obtain gj(I∗4)(j=1,2,3,4) satisfying
g1(I∗4)+g2(I∗4)+g3(I∗4)+g4(I∗4)=−a1(I∗4)<0 | (3.21) |
and
g1(I∗4)g2(I∗4)g3(I∗4)g4(I∗4)=a4(I∗4)>0. |
Therefore, if Re(gj(I∗4))<0(j=1,2,3,4), the endemic equilibrium P∗4 of system (2.1) is stable. However, if Re(g1(I∗4))≤Re(g2(I∗4))<0<Re(g3(I∗4))≤Re(g4(I∗4)) and |Re(g1(I∗4))|+|Re(g2(I∗4))|>|Re(g3(I∗4))|+|Re(g4(I∗4))|, the endemic equilibrium P∗4 of system (2.1) is unstable. Thus, the stability of the endemic equilibrium P∗4 is uncertain. This completes the proof of Theorem 4.
Theorem 5. (ⅰ) If R01<1, system (2.1) exhibits a forward bifurcation at R0=1.
(ⅱ)If R01>1, system (2.1) exhibits a backward bifurcation at R0=1.
Proof. We suppose x1=S,x2=E,x3=I,x4=R,x5=M, system (2.1) becomes
{dx1dt=δ−βx1x3e−αx5−μx1:=f1,dx2dt=(1−q)βx1x3e−αx5−(μ+ε)x2:=f2,dx3dt=qβx1x3e−αx5+εx2−(d+μ+γ)x3:=f3,dx4dt=γx3−μx4:=f4,dx5dt=μ1x1+μ2x2+μ3x3+μ4x4−τx5:=f5. |
When R0=1, we obtain β=βc=μ(μ+ε)(d+μ+γ)δ(ε+μq)eαμ1δμτ. When β=βc, the Jacobian matrix corresponding to system (2.1) about the disease-free equilibrium P0=x0=(δμ,0,0,0,μ1δμτ) is given by
J(x0)=(−μ0−(μ+ε)(d+μ+γ)ε+μq000−(μ+ε)(1−q)(μ+ε)(d+μ+γ)ε+μq000εq(μ+ε)(d+μ+γ)ε+μq−(μ+d+γ)0000γ−μ0μ1μ2μ3μ4−τ). |
It is clear that 0 is a simple eigenvalue of J(x0). A right eigenvector ω corresponding to the 0 eigenvalue is ω=(ω1,ω2,ω3,ω4,ω5)T, where
ω1=−(μ+ε)(d+μ+γ)μ,ω2=(1−q)(d+μ+γ),ω3=ε+μq,ω4=γ(ε+μq)μ,ω5=−(ε+μq)Φα. |
The left eigenvector υ corresponding to the 0 eigenvalue satisfying υJ=0 and υω=1 is υ=(υ1,υ2,υ3,υ4,υ5), where
υ1=υ4=υ5=0,υ2=1(1−q)(d+μ+γ)+(ε+μq)(μ+ε), |
υ3=μ+εε[(1−q)(d+μ+γ)+(ε+μq)(μ+ε)]. |
Furthermore, we have a=5∑k,i,j=1υkωiωj∂2fk(x0)∂xi∂xj and b=5∑k,i=1υkωi∂2fk(x0)∂xi∂β. Substituting the values of all second order derivatives evaluated at the disease-free equilibrium x0=(δμ,0,0,0,μ1δμτ), we obtain
a=2υ2ω1ω3∂2f2(x0)∂x1∂x3+2υ2ω3ω5∂2f2(x0)∂x3∂x5+2υ3ω1ω3∂2f3(x0)∂x1∂x3+2υ3ω3ω5∂2f3(x0)∂x3∂x5=2βe−αμ1δμτ(ω1ω3−αδμω3ω5)(υ2(1−q)+υ3q)=2β(ε+μq)2(μ+ε)(d+μ+γ)(R01−1)e−αμ1δμτμε[(1−q)(d+μ+γ)+(ε+μq)(μ+ε)], |
and
b=υ2ω3∂2f2(x0)∂x3∂β+υ3ω3∂2f3(x0)∂x3∂β=ω3δμe−αμ1δμτ[(1−q)υ2+qυ3]=δ(ε+μq)2e−αμ1δμτμε[(1−q)(d+μ+γ)+(ε+μq)(μ+ε)]. |
According to Theorem 4.1 of [25], note that the coefficient b is always positive. If R01<1, the coefficient a is negative. In this case, the direction of the bifurcation of system (2.1) at R0=1 is forward. If R01>1, the coefficient a is positive. Under this circumstance, the direction of the bifurcation of system (2.1) at R—0=1 is backward. This completes the proof of Theorem 5.
In this section, we will give some simulations using the parameter values which are given in Table 1.
Parameter | Description | Estimated value | Source |
δ | Constant recruitment rate of the population | 0.8day−1 | [14] |
β | Transmission coefficient of TB | 0.0099-0.8person−1day−1 | Estimate |
α | The coefficient that determines how effective TB | 0.00091-0.8day−1 | [14] |
information can influence the transmission rate | |||
μ | Nature death rate | 0.009-0.6year−1 | Estimate |
q | The proportion of disease by fast progression | 0-0.5year−1 | Estimate |
ε | The progression rate from E to I | 0.02-0.99day−1 | Estimate |
d | The disease-related death rate of TB | 0.002-0.5day−1 | Estimate |
γ | The recovery rate of TB | 0.006-0.99day−1 | Estimate |
μ1 | The rate that susceptible individuals may send | 0.04-0.99day−1 | [26] |
message about TB | |||
μ2 | The rate that exposed individuals may send | 0.008-0.8day−1 | [26] |
message about TB | |||
μ3 | The rate that infectious individuals may send | 0.08-0.8day−1 | [26] |
message about TB | |||
μ4 | The rate that recovered individuals may send | 0-1day−1 | Estimate |
message about TB | |||
τ | The rate that message become outdated | 0.03-0.6year−1 | [26] |
We choose a set of the following parameters: δ=0.8, β=0.8, α=0.08, μ=0.6, q=0.5, ε=0.09, d=0.02, γ=0.7, μ1=0.99, μ2=0.4, μ3=0.8, μ4=0.8, τ=0.6. It is easy to check that the basic reproductive number R0=0.383<1. Then the unique disease-free equilibrium P0=(1.3333,0,0,0,2.2) of system (2.1) is globally asymptotically stable (see Figure 2).
Next, we select a set of the following parameters: δ=0.8, β=0.8, α=0.08, μ=0.2, q=0.1, ε=0.4, d=0.02, γ=0.6, μ1=0.2, μ2=0.8, μ3=0.8, μ4=0.8, τ=0.6. It is easy to check that the basic reproductive number R0=2.4553>1. Then, from Theorem 4, the endemic equilibrium P∗1 of system (2.1) is locally asymptotically stable when R0>max(1,R01), where R01=−0.0158 (see Figure 3).
The backward and forward bifurcation diagram of system (2.1) is shown in Figure 4, and the direction of bifurcation depends upon the value of R01. As seen in the backward bifurcation diagram of Figure 4(a) when R01=4.4936>1, there is a threshold quantity Rc which is the value of R0. The disease-free equilibrium is globally asymptotically stable when R0<Rc, where Rc=0.1350. There are two endemic equilibria and a disease-free equilibrium when Rc<R0<1, the upper ones are stable, the middle ones are unstable and the lower ones is globally asymptotically stable. There is a stable endemic equilibrium and an unstable disease-free equilibrium when R0>1. As seen in the forward bifurcation diagram of Figure 4(b) when R01=0.5357<1, the disease-free equilibrium is globally asymptotically stable when R0<1. There are a stable endemic equilibrium and an unstable disease-free equilibrium when R0>1.
In this section, we discuss sensitivity analysis of the basic reproductive number R0 and the infectious individuals I at first. We study the influence of α, μ1 and β to R0. It is straightforward from (3.2) that R0 increases as β increases. This agrees with the intuition that higher transmission coefficient increases the basic reproduction number. In order to see the relationship of these parameters and R0, we regard R0 as a function about those parameters. Note that
∂R0∂α=−(ε+μq)βδ2μ1e−αμ1δμτμ2τ(μ+ε)(d+μ+γ)<0, |
∂R0∂μ1=−(ε+μq)αβδ2e−αμ1δμτμ2τ(μ+ε)(d+μ+γ)<0, |
∂R0∂q=μβδe−αμ1δμτμ(μ+ε)(d+μ+γ)>0. |
Therefore, we find that α and μ1 have a negative influence on the basic reproductive number R0. However, q has a positive influence on the basic reproductive number R0. The parameter values are δ=0.8, q=0.1, β=0.8, μ=0.2, ε=0.4, γ=0.6, d=0.02, μ2=0.8, μ3=0.8, μ4=0.8, τ=0.6. From Figure 5, we know that the basic reproductive number R0 will decrease when α and μ1 increase. However, the basic reproductive number R0 will increase when q increases.
Next, in order to evaluate the effect of media coverage on the dynamics of tuberculosis, we choose different values of α and τ (see Figure 6). The parameters are δ=0.8, q=0.1, β=0.8,μ=0.2, ε=0.4, γ=0.6, d=0.02, μ1=0.2, μ2=0.8, μ3=0.8, μ4=0.8.
From Figure 6, we know that infected number will decrease when α increase, and increase when τ increases. Therefore, we find that media coverage has a great impact on the transmission of tuberculosis.
Choosing β as a parameter, it is also observed that with β increasing, the positive equilibrium point P∗1 loses its stability and a Hopf bifurcation occurs when β passes a critical values β∗.
We select a set of the following parameters: δ=0.8, β=0.0099, α=0.007, μ=0.009, q=0.1, ε=0.99, d=0.5, γ=0.99, μ1=0.08, μ2=0.8, μ3=0.8, μ4=0.8, τ=0.6. The endemic equilibrium P∗1 of system (2.1) is locally asymptotically stable when R0>max{1,R01} and β<β∗ (see Figure 7).
To illustrate the existence of Hopf bifurcation, we choose a set of the following parameters: δ=0.8, α=0.007, μ=0.009, q=0.5, ε=0.99, d=0.02, γ=0.1, μ1=0.09, μ2=0.008, μ3=0.08, μ4=0.08, τ=0.03. When β passes through the critical value β∗, we find the positive endemic equilibrium P∗1 loses its stability and a Hopf bifurcation occurs (see Figure 8).
In this paper, we propose and analyse a TB model with fast and slow progression and media coverage. By means of the next-generation matrix, we obtain the basic reproductive number R0, which plays a crucial role in our model. By constructing Lyapunov function, we prove the global stability of the disease-free equilibrium. In addition, we obtain the existence and the local stability of the endemic equilibrium. By using the center manifold theory, we get a backward and forward bifurcation. Furthermore, we give a numerical result about a Hopf bifurcation occurs when β passes through the critical value β∗. At last, we also use numerical method to simulate outcomes which we have been proved.
The initially exposed individuals have a higher risk of developing active TB. They still have the possibility of progressing to infectious TB with time passing. The likelihood of becoming an active infectious case decreases with the age of the infection. Taking these factors into consideration, we set up a new tuberculosis with fast and slow progression and media coverage. Through simulations, we know that β plays an important role and induces Hopf bifucation in our model. Furthermore, we have done some simulations (not shown). We did not find other critical parameters (including q) for Hopf bifurcation. q is the proportion of disease by fast progression. Since R0=ρ(FV−1)=(ε+μq)βδe−αμ1δμτμ(μ+ε)(d+μ+γ), we can find the basic reproductive number R0 will increase when q increases. Tuberculosis may breakout due to the increase of q. The fast and slow progression can not induce Hopf bifurcation, but it still plays an important role in TB transmission and has a positive influence on the basic reproductive number R0.
Our results show that media coverage has a substantial influence on the dynamics of tuberculosis and it can greatly influence the spread of the tuberculosis, thus, it is crucial to remind people to take countermeasures to avoid potential infections by media coverage.
In our model (2.1), we only consider the form of ordinary equation. Note that all of the people have a time delay in releasing and receiving information, it is more realistic to explore a time delay in the rate that media coverage become outdated. On the other hand, as suggested by Styblo et al. [27], recovered individuals may only have partial immunity. Indeed, TB is one kind of chronic infectious diseases that has a certain relapse rate due to the drug-resistant tuberculosis and lack of combination drug regimen. Thus, it is a very interesting and more realistic to study our model with reinfection, that is some individuals in the recovered class can relapse back into the active TB state. We leave these interesting works for the future.
The authors are very grateful to the Editor-in-Chief and the anonymous referees for their valuable comments and suggestions which helped us to improve the paper. This work is supported by the National Natural Science Foundation of China (11861044 and 11661050), and the HongLiu first-class disciplines Development Program of Lanzhou University of Technology.
The authors declare there is no conflict of interest.
[1] | J. Liu, H. Dang, X. W. Wang, The significance of intertumor and intratumor heterogeneity in liver cancer, Exp. Mol. Med., 50 (2018), e416. |
[2] |
T. M. Grzywa, W. Paskal, P. K. Włodarski, Intratumor and intertumor heterogeneity in melanoma, Transl. Oncol., 10 (2017), 956-975. doi: 10.1016/j.tranon.2017.09.007
![]() |
[3] | K. Anderson, C. Lutz, F. W. Van Delft, C. M. Bateman, Y. Guo, S. M. Colman, et al., Genetic variegation of clonal architecture and propagating cells in leukaemia, Nature, 469 (2011), 356-361. |
[4] | S. Li, F. E. Garrett-Bakelman, S. S. Chung, M. A. Sanders, T. Hricik, F. Rapaport, et al., Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia, Nat. Med., 22 (2016), 792-799. |
[5] | G. C. Webb, D. D. Chaplin, Genetic variability at the human tumor necrosis factor loci., J. Immunol., 145 (1990), 1278-1285. |
[6] |
A. Marusyk, K. Polyak, Tumor heterogeneity: Causes and consequences, Biochim. Biophys. Acta, Rev. Cancer, 1805 (2010), 105-117. doi: 10.1016/j.bbcan.2009.11.002
![]() |
[7] | A. A. Alizadeh, V. Aranda, A. Bardelli, C. Blanpain, C. Bock, C. Borowski, et al., Toward understanding and exploiting tumor heterogeneity, Nat. Med., 21 (2015), 846-853. |
[8] | M. Lee, G. T. Chen, E. Puttock, K. Wang, R. A. Edwards, M. L. Waterman, et al., Mathematical modeling links wnt signaling to emergent patterns of metabolism in colon cancer, Mol. Syst. Biol., 13 (2017), 912. |
[9] |
S. Terry, S. Buart, S. Chouaib, Hypoxic stress-induced tumor and immune plasticity, suppression, and impact on tumor heterogeneity, Front. Immunol., 8 (2017), 1625. doi: 10.3389/fimmu.2017.01625
![]() |
[10] | S. Akgul, A.-M. Patch, R. C. J. D'Souza, P. Mukhopadhyay, K. Nones, S. Kempe, et al., ¨ Intratumoural heterogeneity underlies distinct therapy responses and treatment resistance in glioblastoma, Cancers, 11 (2019), 190. |
[11] |
T. D. Laajala, T. Gerke, S. Tyekucheva, J. C. Costello, Modeling genetic heterogeneity of drug response and resistance in cancer, Curr. Opin. Syst. Biol., 17 (2019), 8-14. doi: 10.1016/j.coisb.2019.09.003
![]() |
[12] |
X. Ma, J. Huang, Predicting clinical outcome of therapy-resistant prostate cancer, Proc. Natl. Acad. Sci., 116 (2019), 11090-11092. doi: 10.1073/pnas.1906812116
![]() |
[13] |
A. M. Stein, T. Demuth, D. Mobley, M. Berens, L. M. Sander, A mathematical model of glioblastoma tumor spheroid invasion in a three-dimensional in vitro experiment, Biophys. J., 92 (2007), 356-365. doi: 10.1529/biophysj.106.093468
![]() |
[14] |
T. L. Stepien, E. M. Rutter, Y. Kuang, Traveling waves of a go-or-grow model of glioma growth, SIAM J. Appl. Math., 78 (2018), 1778-1801. doi: 10.1137/17M1146257
![]() |
[15] |
A. Martínez-González, G. F. Calvo, L. A. P. Romasanta, V. M. Pérez-García, Hypoxic cell waves around necrotic cores in glioblastoma: A biomathematical model and its therapeutic implications, Bull. Math. Biol., 74 (2012), 2875-2896. doi: 10.1007/s11538-012-9786-1
![]() |
[16] |
H. Hatzikirou, D. Basanta, M. Simon, K. Schaller, A. Deutsch, 'Go or grow': The key to the emergence of invasion in tumour progression?, Math. Med. Biol.: A J. IMA, 29 (2012), 49-65. doi: 10.1093/imammb/dqq011
![]() |
[17] |
Z. Husain, P. Seth, V. P. Sukhatme, Tumor-derived lactate and myeloid-derived suppressor cells: Linking metabolism to cancer immunology, Oncoimmunology, 2 (2013), e26383. doi: 10.4161/onci.26383
![]() |
[18] |
A. N. Mendler, B. Hu, P. U. Prinz, M. Kreutz, E. Gottfried, E. Noessner, Tumor lactic acidosis suppresses CTL function by inhibition of p38 and JNK/c-Jun activation, Int. J. Cancer, 131 (2012), 633-640. doi: 10.1002/ijc.26410
![]() |
[19] | K. Fischer, P. Hoffmann, S. Voelkl, N. Meidenbauer, J. Ammer, M. Edinger, et al., Inhibitory effect of tumor cell-derived lactic acid on human T cells, Blood, 109 (2007), 3812-3819. |
[20] |
E. C. Fiedler, M. T. Hemann, Aiding and abetting: How the tumor microenvironment protects cancer from chemotherapy, Annu. Rev. Cancer Biol., 3 (2019), 409-428. doi: 10.1146/annurev-cancerbio-030518-055524
![]() |
[21] | J. K. Saggar, M. Yu, Q. Tan, I. F. Tannock, The tumor microenvironment and strategies to improve drug distribution, Front. Oncol., 3 (2013), 154. |
[22] |
A. I. Minchinton, I. F. Tannock, Drug penetration in solid tumours, Nat. Rev. Cancer, 6 (2006), 583-592. doi: 10.1038/nrc1893
![]() |
[23] | A. Baldock, R. Rockne, A. Boone, M. Neal, C. Bridge, L. Guyman, et al., From patient-specific mathematical neuro-oncology to precision medicine, Front. Oncol., 3 (2013), 62. |
[24] | A. L. Baldock, S. Ahn, R. Rockne, S. Johnston, M. Neal, D. Corwin, et al., Patient-specific metrics of invasiveness reveal significant prognostic benefit of resection in a predictable subset of gliomas, PLoS One, 9 (2014), e99057. |
[25] |
S. Barish, M. F. Ochs, E. D. Sontag, J. L. Gevertz, Evaluating optimal therapy robustness by virtual expansion of a sample population, with a case study in cancer immunotherapy, Proc. Nati. Acad. Sci., 114 (2017), E6277-E6286. doi: 10.1073/pnas.1703355114
![]() |
[26] | J. C. L. Alfonso, L. Berk, Modeling the effect of intratumoral heterogeneity of radiosensitivity on tumor response over the course of fractionated radiation therapy, Radiat. Oncol., 14 (2019), 88. |
[27] |
F. Forouzannia, H. Enderling, M. Kohandel, Mathematical modeling of the effects of tumor heterogeneity on the efficiency of radiation treatment schedule, Bull. Math. Biol., 80 (2018), 283-293. doi: 10.1007/s11538-017-0371-5
![]() |
[28] |
C. H. Morrell, J. D. Pearson, H. B. Carter, L. J. Brant, Estimating unknown transition times using a piecewise nonlinear mixed-effects model in men with prostate cancer, J. Am. Stat. Assoc., 90 (1995), 45-53. doi: 10.1080/01621459.1995.10476487
![]() |
[29] | N. Hartung, S. Mollard, D. Barbolosi, A. Benabdallah, G. Chapuisat, G. Henry, et al., Mathematical modeling of tumor growth and metastatic spreading: Validation in tumor-bearing mice, Cancer Res., 74 (2014), 6397-6407. |
[30] |
J. Poleszczuk, R. Walker, E. G. Moros, K. Latifi, J. J. Caudell, H. Enderling, Predicting patientspecific radiotherapy protocols based on mathematical model choice for proliferation-saturation index, Bull. Math. Biol., 80 (2018), 1195-1206. doi: 10.1007/s11538-017-0279-0
![]() |
[31] | A. Rafii, C. Touboul, H. A. Thani, K. Suhre, J. A. Malek, Where cancer genomics should go next: a clinician's perspective, Hum. Mol. Genet., 23 (2014), R69-R75. |
[32] |
D. Zardavas, A. Irrthum, C. Swanton, M. Piccart, Clinical management of breast cancer heterogeneity, Nat. Rev. Clin. Oncol., 12 (2015), 381-394. doi: 10.1038/nrclinonc.2015.73
![]() |
[33] |
A. D. Barker, C. C. Sigman, G. J. Kelloff, N. M. Hylton, D. A. Berry, L. J. Esserman, I-spy 2: an adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy, Clin. Pharmacol. Ther., 86 (2009), 97-100. doi: 10.1038/clpt.2009.68
![]() |
[34] |
A. S. Meyer, L. M. Heiser, Systems biology approaches to measure and model phenotypic heterogeneity in cancer, Curr. Opin. Syst. Biol., 17 (2019), 35-40. doi: 10.1016/j.coisb.2019.09.002
![]() |
[35] | R. A. Gatenby, E. T. Gawlinski, A reaction-diffusion model of cancer invasion, Cancer Res., 56 (1996), 5745-5753. |
[36] |
P. Tracqui, G. C. Cruywagen, D. E. Woodward, G. T. Bartoo, J. D. Murray, E. Alvord Jr, A mathematical model of glioma growth: the effect of chemotherapy on spatio-temporal growth, Cell Proliferation, 28 (1995), 17-31. doi: 10.1111/j.1365-2184.1995.tb00036.x
![]() |
[37] |
M. A. J. Chaplain, Reaction-diffusion prepatterning and its potential role in tumour invasion, J. Biol. Syst., 3 (1995), 929-936. doi: 10.1142/S0218339095000824
![]() |
[38] |
H. L. Harpold, E. C. Alvord Jr, K. R. Swanson, The evolution of mathematical modeling of glioma proliferation and invasion, J. Neuropathol. Exp. Neurol., 66 (2007), 1-9. doi: 10.1097/nen.0b013e31802d9000
![]() |
[39] | R. Rockne, J. K. Rockhill, M. Mrugala, A. M. Spence, I. Kalet, K. Hendrickson, et al., Predicting the efficacy of radiotherapy in individual glioblastoma patients in vivo: a mathematical modeling approach, Phys. Med. Biol., 55 (2010), 3271. |
[40] | T. E. Yankeelov, N. Atuegwu, D. Hormuth, J. A. Weis, S. L. Barnes, M. I. Miga, et al., Clinically relevant modeling of tumor growth and treatment response, Sci. Transl. Med., 5 (2013), 187ps9-187ps9. |
[41] | D. A. Hormuth II, J. A. Weis, S. L. Barnes, M. I. Miga, E. C. Rericha, V. Quaranta, et al., Predicting in vivo glioma growth with the reaction diffusion equation constrained by quantitative magnetic resonance imaging data, Phys. Biol., 12 (2015), 046006. |
[42] |
K. R. Swanson, R. C. Rostomily, E. C. Alvord Jr, A mathematical modelling tool for predicting survival of individual patients following resection of glioblastoma: A proof of principle, Br. J. Cancer, 98 (2008), 113-119. doi: 10.1038/sj.bjc.6604125
![]() |
[43] | S. Prokopiou, E. G. Moros, J. Poleszczuk, J. Caudell, J. F. Torres-Roca, K. Latifi, et al., A proliferation saturation index to predict radiation response and personalize radiotherapy fractionation, Radiat. Oncol., 10 (2015), 159. |
[44] | C. Vaghi, A. Rodallec, R. Fanciullino, J. Ciccolini, J. Mochel, M. Mastri, et al., Population modeling of tumor growth curves, the reduced Gompertz model and prediction of the age of a tumor, in Mathematical and Computational Oncology (eds. G. Bebis, T. Benos, K. Chen, K. Jahn, E. Lima), Lecture Notes in Computer Science, Springer International Publishing, Cham, (2019), 87-97. |
[45] | T. J. Sullivan, Introduction to Uncertainty Quantification, Springer, 2015. |
[46] | G. J. Lord, C. E. Powell, T. Shardlow, Introduction to Computational Stochastic PDEs, Cambridge, 2014. |
[47] | R. Smith, Uncertainty Quantification: Theory, Implementation, and Applications, SIAM, 2014. |
[48] | N. Henscheid, E. Clarkson, K. J. Myers, H. H. Barrett, Physiological random processes in precision cancer therapy, PLoS One, 13 (2018), e0199823. |
[49] |
J. P. O'Connor, C. J. Rose, J. C. Waterton, R. A. Carano, G. J. Parker, A. Jackson, Imaging intratumor heterogeneity: Role in therapy response, resistance, and clinical outcome, Clin. Cancer Res., 21 (2015), 249-257. doi: 10.1158/1078-0432.CCR-14-0990
![]() |
[50] |
R. J. Allen, T. R. Rieger, C. J. Musante, Efficient generation and selection of virtual populations in quantitative systems pharmacology models, CPT: Pharmacometrics Syst. Pharmacol., 5 (2016), 140-146. doi: 10.1002/psp4.12063
![]() |
[51] | T. R. Rieger, R. J. Allen, L. Bystricky, Y. Chen, G. W. Colopy, Y. Cui, et al., Improving the generation and selection of virtual populations in quantitative systems pharmacology models, Prog. Biophys. Mol. Biol., 139 (2018), 15-22. |
[52] |
D. J. Klinke, Integrating epidemiological data into a mechanistic model of type 2 diabetes: Validating the prevalence of virtual patients, Ann. Biomed. Eng., 36 (2008), 321-334. doi: 10.1007/s10439-007-9410-y
![]() |
[53] |
B. J. Schmidt, F. P. Casey, T. Paterson, J. R. Chan, Alternate virtual populations elucidate the type i interferon signature predictive of the response to rituximab in rheumatoid arthritis, BMC Bioinf., 14 (2013), 221. doi: 10.1186/1471-2105-14-221
![]() |
[54] | J. Bassaganya-Riera, Accelerated Path to Cures, Springer, 2018. |
[55] | N. Henscheid, Quantifying Uncertainties in Imaging-Based Precision Medicine, Ph.D thesis, University of Arizona, 2018. |
[56] | J. G. Albeck, J. M. Burke, S. L. Spencer, D. A. Lauffenburger, P. K. Sorger, Modeling a snapaction, variable-delay switch controlling extrinsic cell death, PLoS Biol., 6 (2008), e299. |
[57] |
Q. Wu, S. D. Finley, Predictive model identifies strategies to enhance tsp1-mediated apoptosis signaling, Cell Commun. Signaling, 15 (2017), 53. doi: 10.1186/s12964-017-0207-9
![]() |
[58] | M. R. Birtwistle, J. Rauch, A. Kiyatkin, E. Aksamitiene, M. Dobrzyński, J. B. Hoek, et al., Emergence of bimodal cell population responses from the interplay between analog single-cell signaling and protein expression noise, BMC Syst. Biol., 6 (2012), 109. |
[59] | D. Brown, R. A. Namas, K. Almahmoud, A. Zaaqoq, J. Sarkar, D. A. Barclay, et al., Trauma in silico: Individual-specific mathematical models and virtual clinical populations, Sci. Transl. Med., 7 (2015), 285ra61-285ra61. |
[60] | A. Badano, C. G. Graff, A. Badal, D. Sharma, R. Zeng, F. W. Samuelson, et al., Evaluation of digital breast tomosynthesis as replacement of full-field digital mammography using an in silico imaging trial, JAMA Net. Open, 1 (2018), e185474-e185474. |
[61] | W. Kainz, E. Neufeld, W. E. Bolch, C. G. Graff, C. H. Kim, N. Kuster, et al., Advances in computational human phantoms and their applications in biomedical engineering—a topical review, IEEE Trans. Radiat. Plasma Med. Sci., 3 (2019), 1-23. |
[62] | E. Roelofs, M. Engelsman, C. Rasch, L. Persoon, S. Qamhiyeh, D. De Ruysscher, et al., Results of a multicentric in silico clinical trial (rococo): Comparing radiotherapy with photons and protons for non-small cell lung cancer, J. Thorac. Oncol., 7 (2012), 165-176. |
[63] |
J. K. Birnbaum, F. O. Ademuyiwa, J. J. Carlson, L. Mallinger, M. W. Mason, R. Etzioni, Comparative effectiveness of biomarkers to target cancer treatment: Modeling implications for survival and costs, Med. Decis. Making, 36 (2016), 594-603. doi: 10.1177/0272989X15601998
![]() |
[64] |
D. Li, S. D. Finley, The impact of tumor receptor heterogeneity on the response to anti-angiogenic cancer treatment, Integr. Biol., 10 (2018), 253-269. doi: 10.1039/C8IB00019K
![]() |
[65] |
K. Mustapha, Q. Gilli, J.-M. Frayret, N. Lahrichi, E. Karimi, Agent-based simulation patient model for colon and colorectal cancer care trajectory, Procedia Comput. Sci., 100 (2016), 188-197. doi: 10.1016/j.procs.2016.09.140
![]() |
[66] |
J. P. Rolland, H. H. Barrett, Effect of random background inhomogeneity on observer detection performance, J. Opt. Soc. Am. A, 9 (1992), 649-658. doi: 10.1364/JOSAA.9.000649
![]() |
[67] | H. H. Barrett, K. J. Myers, Foundations of Image Science, NY: John Wiley and Sons, New York, 2004. |
[68] |
M. A. Kupinski, E. Clarkson, J. W. Hoppin, L. Chen, H. H. Barrett, Experimental determination of object statistics from noisy images, JOSA A, 20 (2003), 421-429. doi: 10.1364/JOSAA.20.000421
![]() |
[69] |
F. Bochud, C. Abbey, M. Eckstein, Statistical texture synthesis of mammographic images with clustered lumpy backgrounds, Opt. Express, 4 (1999), 33-42. doi: 10.1364/OE.4.000033
![]() |
[70] | N. Henscheid, Generating patient-specific virtual tumor populations with reaction-diffusion models and molecular imaging data, Math. Biosci. Eng., Submitted. |
[71] | W. Hundsdorfer, J. G. Verwer, Numerical solution of time-dependent advection-diffusion-reaction equations, Springer Science and Business Media, 2013. |
[72] | S. KM, M. Prah, Data from brain-tumor-progression, The Cancer Imaging Archive, 2018. |
[73] |
M. Davidian, D. M. Giltinan, Nonlinear models for repeated measurement data: An overview and update, J. Agric., Biol., and Environ. Stat., 8 (2003), 387-419. doi: 10.1198/1085711032697
![]() |
[74] | K. Clark, B. Vendt, K. Smith, J. Freymann, J. Kirby, P. Koppel, et al., The cancer imaging archive (tcia): maintaining and operating a public information repository, J. Digital Imaging, 26 (2013), 1045-1057. |
[75] | S. Desmée, F. Mentré, C. Veyrat-Follet, J. Guedj, Nonlinear mixed-effect models for prostatespecific antigen kinetics and link with survival in the context of metastatic prostate cancer: A comparison by simulation of two-stage and joint approaches, Am. Assoc. Pharm. Sci. J., 17 (2015), 691-699. |
[76] |
A. Król, C. Tournigand, S. Michiels, V. Rondeau, Multivariate joint frailty model for the analysis of nonlinear tumor kinetics and dynamic predictions of death, Stat. Med., 37 (2018), 2148-2161. doi: 10.1002/sim.7640
![]() |
[77] |
E. Grenier, V. Louvet, P. Vigneaux, Parameter estimation in non-linear mixed effects models with SAEM algorithm: extension from ODE to PDE, ESAIM: Math. Modell. Numer. Anal., 48 (2014), 1303-1329. doi: 10.1051/m2an/2013140
![]() |
[78] | H. Liang, Modeling antitumor activity in xenograft tumor treatment, Biom. J.: J. Math. Methods Biosci., 47 (2005), 358-368. |
[79] |
H. Liang, N. Sha, Modeling antitumor activity by using a non-linear mixed-effects model, Math. Biosci., 189 (2004), 61-73. doi: 10.1016/j.mbs.2004.01.002
![]() |
[80] | A. M. Stein, D. Bottino, V. Modur, S. Branford, J. Kaeda, J. M. Goldman, et al., Bcr-abl transcript dynamics support the hypothesis that leukemic stem cells are reduced during imatinib treatment, Clin. Cancer Res., 17 (2011), 6812-6821. |
[81] | T. Ferenci, J. Sápi, L. Kovács, Modelling tumor growth under angiogenesis inhibition with mixed-effects models, Acta Polytech. Hung., 14 (2017), 221-234. |
[82] | B. Ribba, G. Kaloshi, M. Peyre, D. Ricard, V. Calvez, M. Tod, et al., A tumor growth inhibition model for low-grade glioma treated with chemotherapy or radiotherapy, Clin. Cancer Res., 18 (2012), 5071-5080. |
[83] | B. Ribba, N. H. Holford, P. Magni, I. Trocóniz, I. Gueorguieva, P. Girard, et al., A review of mixed-effects models of tumor growth and effects of anticancer drug treatment used in population analysis, CPT: Pharmacometrics Syst. Pharmacol., 3 (2014), 1-10. |
[84] | N. W. Shock, R. C. Greulich, R. Andres, D. Arenberg, P. T. Costa, E. G. Lakatta, et al., Normal human aging. the baltimore longituidinal study of aging, U.S. Government Printing Office Publication. |
[85] | https://www.mathworks.com/help/stats/nlmefit.html, accessed November 16, 2019. |
[86] | H. T. Banks, V. A. Bokil, S. Hu, A. K. Dhar, R. A. Bullis, C. L. Browdy, et al., Modeling shrimp biomass and viral infection for production of biological countermeasures, Math. Biosci. Eng., 3 (2006), 635-660. |
[87] |
H. T. Banks, J. L. Davis, A comparison of approximation methods for the estimation of probability distributions on parameters, Appl. Numer. Math., 57 (2007), 753-777. doi: 10.1016/j.apnum.2006.07.016
![]() |
[88] | M. Sirlanci, S. E. Luczak, C. E. Fairbairn, D. Kang, R. Pan, X. Yu, et al., Estimating the distribution of random parameters in a diffusion equation forward model for a transdermal alcohol biosensor, Automatica, 106 (2019), 101-109. |
[89] |
E. M. Rutter, H. T. Banks, K. B. Flores, Estimating intratumoral heterogeneity from spatiotemporal data, J. Math. Biol., 77 (2018), 1999-2022. doi: 10.1007/s00285-018-1238-6
![]() |
[90] | H. T. Banks, K. B. Flores, I. G. Rosen, E. M. Rutter, M. Sirlanci, W. C. Thompson, The prohorov metric framework and aggregate data inverse problems for random pdes, Commun. Appl. Anal., 22 (2018), 415-446. |
[91] | H. T. Banks, W. C. Thompson, Existence and consistency of a nonparametric estimator of probability measures in the prohorov metric framework, Int. J. Pure Appl. Math., 103 (2015), 819-843. |
[92] | H. Akaike, A new look at the statistical model identification, in Selected Papers of Hirotugu Akaike (eds. E. Parzen, K. Tanabe, G. Kitagawa), Springer New York, New York, (1998), 215-222. |
[93] | R. Ullrich, H. Backes, H. Li, L. Kracht, H. Miletic, K. Kesper, et al., Glioma proliferation as assessed by 3-fluoro-3-deoxy-l-thymidine positron emission tomography in patients with newly diagnosed high-grade glioma, Clin. Cancer Res., 14 (2008), 2049-2055. |
[94] | E. Stretton, E. Geremia, B. Menze, H. Delingette, N. Ayache, Importance of patient dti's to accurately model glioma growth using the reaction diffusion equation, in 2013 IEEE 10th Int. Symp. Biomed. Imaging, IEEE, 2013, 1142-1145. |
[95] | N. C. Atuegwu, D. C. Colvin, M. E. Loveless, L. Xu, J. C. Gore, T. E. Yankeelov, Incorporation of diffusion-weighted magnetic resonance imaging data into a simple mathematical model of tumor growth, Phys. Med. Biol., 57 (2011), 225-240. |
[96] | J. Lipková, P. Angelikopoulos, S. Wu, E. Alberts, B. Wiestler, C. Diehl, et al., Personalized radiotherapy design for glioblastoma: Integrating mathematical tumor models, multimodal scans, and bayesian inference, IEEE Trans. Med. Imaging, 38 (2019), 1875-1884. |
[97] | J. Kaipio, E. Somersalo, Statistical and Computational Inverse Problems, Springer Science and Business Media, 2006. |
[98] |
A. M. Stuart, Inverse problems: a bayesian perspective, Acta Numer., 19 (2010), 451-559. doi: 10.1017/S0962492910000061
![]() |
[99] |
P. R. Jackson, J. Juliano, A. Hawkins-Daarud, R. C. Rockne, K. R. Swanson, Patient-specific mathematical neuro-oncology: using a simple proliferation and invasion tumor model to inform clinical practice, Bull. Math. Biol., 77 (2015), 846-856. doi: 10.1007/s11538-015-0067-7
![]() |
[100] | J. Oden, Cse 397 Lecture Notes: Foundations of Predictive Computational Science, 2017. Available from: https://www.oden.utexas.edu/media/reports/2017/1701.pdf. |
[101] | J. Collis, A. J. Connor, M. Paczkowski, P. Kannan, J. Pitt-Francis, H. M. Byrne, et al., Bayesian calibration, validation and uncertainty quantification for predictive modelling of tumour growth: A tutorial, Bull. Math. Biol., 79 (2017), 939-974. |
[102] |
E. J. Kostelich, Y. Kuang, J. M. McDaniel, N. Z. Moore, N. L. Martirosyan, M. C. Preul, Accurate state estimation from uncertain data and models: An application of data assimilation to mathematical models of human brain tumors, Biol. Direct, 6 (2011), 64. doi: 10.1186/1745-6150-6-64
![]() |
[103] | A. Hawkins-Daarud, S. Prudhomme, K. G. van der Zee, J. T. Oden, Bayesian calibration, validation, and uncertainty quantification of diffuse interface models of tumor growth, J. Math. Biol., 67 (2013), 1457-1485. |
[104] |
I. Babuška, F. Nobile, R. Tempone, A systematic approach to model validation based on bayesian updates and prediction related rejection criteria, Comput. Methods Appl. Mech. Eng., 197 (2008), 2517-2539. doi: 10.1016/j.cma.2007.08.031
![]() |
[105] | J. T. Oden, E. A. B. F. Lima, R. C. Almeida, Y. Feng, M. N. Rylander, D. Fuentes, et al., Toward predictive multiscale modeling of vascular tumor growth, Arch. Comput. Methods Eng., 23 (2016), 735-779. |
[106] | M. Lê, H. Delingette, J. Kalpathy-Cramer, E. R. Gerstner, T. Batchelor, J. Unkelbach, et al., MRI based bayesian personalization of a tumor growth model, IEEE Trans. Med. Imaging, 35 (2016), 2329-2339. |
[107] | A. Hawkins-Daarud, S. K. Johnston, K. R. Swanson, Quantifying uncertainty and robustness in a biomathematical model-based patient-specific response metric for glioblastoma, JCO Clin. Cancer Inf., 3 (2019), 1-8. |
[108] | I. M. Sobol, Sensitivity estimates for nonlinear mathematical models, Math. Modell. Comput. Exp., 1 (1993), 407-414. |
[109] | P. Constantine, Active Subspaces: Emerging Ideas for Dimension Reduction in Parameter Studies, SIAM, 2015. |
[110] |
M. D. Morris, Factorial sampling plans for preliminary computational experiments, Technometrics, 33 (1991), 161-174. doi: 10.1080/00401706.1991.10484804
![]() |
[111] | C. Rasumssen, C. Williams, Gaussian Processes for Machine Learning, MIT Press, 2006. |
[112] |
X. Zhu, M. Welling, F. Jin, J. Lowengrub, Predicting simulation parameters of biological systems using a gaussian process model, Stat. Anal. Data Mining: ASA Data Sci. J., 5 (2012), 509-522. doi: 10.1002/sam.11163
![]() |
[113] | M. C. Kennedy, A. O'Hagan, Bayesian calibration of computer models, J. R. Stat. Soc.: S. B (Stat. Method., 63 (2001), 425-464. |
[114] | Y. LeCun, L. Bottou, Y. Bengio, P. Haffner, et al., Gradient-based learning applied to document recognition, Proc. IEEE, 86 (1998), 2278-2324. |
[115] | A. Krizhevsky, I. Sutskever, G. E. Hinton, Imagenet classification with deep convolutional neural networks, in Advances in Neural Information Processing Systems (eds. F. Pereira, C. J. C. Burges, L. Bottou, K. Q. Weinberger), Curran Associates, (2012), 1097-1105. |
[116] | O. Ronneberger, P. Fischer, T. Brox, U-net: Convolutional networks for biomedical image segmentation, in Medical Image Computing and Computer-Assisted Intervention (eds. N. Navab, J. Hornegger, W. M. Wells, A. F. Frangi), Springer International Publishing, Cham, (2015), 234-241. |
[117] | A. Esteva, A. Robicquet, B. Ramsundar, V. Kuleshov, M. DePristo, K. Chou, et al., A guide to deep learning in healthcare, Nat. Med., 25 (2019), 24-29. |
[118] | Z. Cao, L. Duan, G. Yang, T. Yue, Q. Chen, An experimental study on breast lesion detection and classification from ultrasound images using deep learning architectures, BMC Med. Imaging, 19 (2019), 51. |
[119] |
D. Ribli, A. Horváth, Z. Unger, P. Pollner, I. Csabai, Detecting and classifying lesions in mammograms with deep learning, Sci. Rep., 8 (2018), 4165. doi: 10.1038/s41598-018-29025-1
![]() |
[120] | E. M. Rutter, J. H. Lagergren, K. B. Flores, Automated object tracing for biomedical image segmentation using a deep convolutional neural network, in Medical Image Computing and Computer Assisted Intervention (eds. A. F. Frangi, J. A. Schnabel, C. Davatzikos, C. Alberola López & G. Fichtinger), Springer International Publishing, Cham, (2018), 686-694. |
[121] | S. Bakas, M. Reyes, A. Jakab, S. Bauer, M. Rempfler, A. Crimi, et al., Identifying the best machine learning algorithms for brain tumor segmentation, progression assessment, and overall survival prediction in the BRATS challenge, preprint, arXiv: 1811.02629. |
[122] | M. Havaei, A. Davy, D. Warde-Farley, A. Biard, A. Courville, Y. Bengio, et al., Brain tumor segmentation with deep neural networks, Med. Image Anal., 35 (2017), 18-31. |
[123] |
Q. Xie, K. Faust, R. Van Ommeren, A. Sheikh, U. Djuric, P. Diamandis, Deep learning for image analysis: Personalizing medicine closer to the point of care, Crit. Rev. Clin. Lab. Sci., 56 (2019), 61-73. doi: 10.1080/10408363.2018.1536111
![]() |
[124] | X. Feng, N. Tustison, C. Meyer, Brain tumor segmentation using an ensemble of 3d U-nets and overall survival prediction using radiomic features, in Brainlesion: Glioma, Multiple Sclerosis, Stroke and Traumatic Brain Injuries (eds. A. Crimi, S. Bakas, H. Kuijf, F. Keyvan, M. Reyes, T. van Walsum), Springer International Publishing, Cham, (2019), 279-288. |
[125] | E. Puybareau, G. Tochon, J. Chazalon, J. Fabrizio, Segmentation of gliomas and prediction of patient overall survival: A simple and fast procedure, in Brainlesion: Glioma, Multiple Sclerosis, Stroke and Traumatic Brain Injuries (eds. A. Crimi, S. Bakas, H. Kuijf, F. Keyvan, M. Reyes & T. van Walsum), Springer International Publishing, Cham, (2019), 199-209. |
[126] | L. Sun, S. Zhang, L. Luo, Tumor segmentation and survival prediction in glioma with deep learning, in Brainlesion: Glioma, Multiple Sclerosis, Stroke and Traumatic Brain Injuries (eds. A. Crimi, S. Bakas, H. Kuijf, F. Keyvan, M. Reyes & T. van Walsum), Springer International Publishing, Cham, (2019), 83-93. |
[127] | B. Lyu, A. Haque, Deep learning based tumor type classification using gene expression data, in Proceedings of the 2018 ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics, ACM, New York, (2018), 89-96. |
[128] | P. Mobadersany, S. Yousefi, M. Amgad, D. A. Gutman, J. S. Barnholtz-Sloan, J. E. V. Vega, et al., Predicting cancer outcomes from histology and genomics using convolutional networks, Proc. Natl. Acad. Sci., 115 (2018), E2970-E2979. |
[129] | J. Zou, M. Huss, A. Abid, P. Mohammadi, A. Torkamani, A. Telenti, A primer on deep learning in genomics, Nat. Genet., 12-18. |
[130] | B. Shickel, P. J. Tighe, A. Bihorac & P. Rashidi, Deep EHR: A survey of recent advances in deep learning techniques for electronic health record (EHR) analysis, IEEE J. Biomed. Health Inf., 22 (2017), 1589-1604. |
[131] | R. A. Taylor, J. R. Pare, A. K. Venkatesh, H. Mowafi, E. R. Melnick, W. Fleischman, et al., Prediction of in-hospital mortality in emergency department patients with sepsis: a local big data-driven, machine learning approach, Academic Emerg. Med., 23 (2016), 269-278. |
[132] | T. Zheng, W. Xie, L. Xu, X. He, Y. Zhang, M. You, et al., A machine learning-based framework to identify type 2 diabetes through electronic health records, Int. J. Med. Inf., 97 (2017), 120-127. |
[133] | H. Xu, Z. Fu, A. Shah, Y. Chen, N. B. Peterson, Q. Chen, et al., Extracting and integrating data from entire electronic health records for detecting colorectal cancer cases, in AMIA Annual Symposium Proceedings, American Medical Informatics Association, (2011), 1564. |
[134] |
D. Zhao, C. Weng, Combining pubmed knowledge and ehr data to develop a weighted bayesian network for pancreatic cancer prediction, J. Biomed. Inf., 44 (2011), 859-868. doi: 10.1016/j.jbi.2011.05.004
![]() |
[135] |
R. Caruana, Multitask learning, Mach. Learn., 28 (1997), 41-75. doi: 10.1023/A:1007379606734
![]() |
[136] | S. Ruder, An overview of multi-task learning in deep neural networks, preprint, arXiv: 1706.05098. |
[137] | N. Jaques, S. Taylor, E. Nosakhare, A. Sano, R. Picard, Multi-task learning for predicting health, stress, and happiness, in NIPS Workshop on Machine Learning for Healthcare, 2016. |
[138] | R. C. Rockne, A. Hawkins-Daarud, K. R. Swanson, J. P. Sluka, J. A. Glazier, P. Macklin, et al., The 2019 mathematical oncology roadmap, Phys. Biol., 16 (2019), 041005. |
[139] |
M. Raissi, P. Perdikaris, G. E. Karniadakis, Physics-informed neural networks: A deep learning framework for solving forward and inverse problems involving nonlinear partial differential equations, J. Comput. Phys., 378 (2019), 686-707. doi: 10.1016/j.jcp.2018.10.045
![]() |
[140] |
S. H. Rudy, S. L. Brunton, J. L. Proctor, J. N. Kutz, Data-driven discovery of partial differential equations, Sci. Adv., 3 (2017), e1602614. doi: 10.1126/sciadv.1602614
![]() |
[141] | J. H. Lagregren, J. T. Nardini, G. M. Lavigne, E. M. Rutter, K. B. Flores, Learning partial differential equations for biological transport models from noisy spatiotemporal data, preprint, arXiv: 1902.04733. |
[142] |
F. Hamilton, A. L. Lloyd, K. B. Flores, Hybrid modeling and prediction of dynamical systems, PLoS Comput. Biol., 13 (2017), e1005655. doi: 10.1371/journal.pcbi.1005655
![]() |
[143] |
J. Lagergren, A. Reeder, F. Hamilton, R. C. Smith, K. B. Flores, Forecasting and uncertainty quantification using a hybrid of mechanistic and non-mechanistic models for an age-structured population model, Bull. Math. Biol., 80 (2018), 1578-1595. doi: 10.1007/s11538-018-0421-7
![]() |
[144] | N. Gaw, A. Hawkins-Daarud, L. S. Hu, H. Yoon, L. Wang, Y. Xu, et al., Integration of machine learning and mechanistic models accurately predicts variation in cell density of glioblastoma using multiparametric MRI, Sci. Rep., 9 (2019), 10063. |
[145] | D. P. Kingma, M. Welling, Auto-encoding variational bayes, preprint,, arXiv: 1312.6114. |
[146] | C. Doersch, Tutorial on variational autoencoders, preprint, arXiv: 1606.05908. |
[147] | A. Myronenko, 3d mri brain tumor segmentation using autoencoder regularization, in Brainlesion: Glioma, Multiple Sclerosis, Stroke and Traumatic Brain Injuries (eds. A. Crimi, S. Bakas, H. Kuijf, F. Keyvan, M. Reyes, T. van Walsum), Springer International Publishing, Cham, (2019), 311-320. |
[148] | J. Xu, L. Xiang, Q. Liu, H. Gilmore, J. Wu, J. Tang, et al., Stacked sparse autoencoder (ssae) for nuclei detection on breast cancer histopathology images, IEEE Trans. Med. Imaging, 35 (2015), 119-130. |
[149] | I. Goodfellow, J. Pouget-Abadie, M. Mirza, B. Xu, D. Warde-Farley, S. Ozair, et al., Generative adversarial nets, in Advances in Neural Information Processing Systems (eds. Z. Ghahramani, M. Welling, C. Cortes, N. D. Lawrence, K. Q. Weinberger), Curran Associates, (2014), 2672-2680. |
[150] | L. Metz, B. Poole, D. Pfau, J. Sohl-Dickstein, Unrolled generative adversarial networks, preprint, arXiv: 1611.02163. |
[151] | M. Arjovsky, L. Bottou, Towards principled methods for training generative adversarial networks, preprint, arXiv: 1701.04862. |
[152] | A. Radford, L. Metz, S. Chintala, Unsupervised representation learning with deep convolutional generative adversarial networks, preprint, arXiv: 1511.06434. |
[153] |
M. Frid-Adar, I. Diamant, E. Klang, M. Amitai, J. Goldberger, H. Greenspan, GANbased synthetic medical image augmentation for increased CNN performance in liver lesion classification, Neurocomputing, 321 (2018), 321-331. doi: 10.1016/j.neucom.2018.09.013
![]() |
[154] | H.-C. Shin, N. A. Tenenholtz, J. K. Rogers, C. G. Schwarz, M. L. Senjem, J. L. Gunter, et al., Medical image synthesis for data augmentation and anonymization using generative adversarial networks, in Simulation and Synthesis in Medical Imaging (eds. A. Gooya, O. Goksel, I. Oguz, N. Burgos), Springer International Publishing, Cham, (2018), 1-11. |
[155] | J.-Y. Zhu, T. Park, P. Isola, A. A. Efros, Unpaired image-to-image translation using cycleconsistent adversarial networks, in The IEEE International Conference on Computer Vision (ICCV), 2017. |
[156] | Y. Zhang, S. Miao, T. Mansi, R. Liao, Task driven generative modeling for unsupervised domain adaptation: Application to x-ray image segmentation, in Medical Image Computing and Computer Assisted Intervention (eds. A. F. Frangi, J. A. Schnabel, C. Davatzikos, C. Alberola-López, G. Fichtinger), Springer International Publishing, Cham, (2018), 599-607. |
[157] | C. E. Gast, A. D. Silk, L. Zarour, L. Riegler, J. G. Burkhart, K. T. Gustafson, et al., Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survival, Sci. Adv., 4 (2018), eaat7828. |
[158] | K. Mitamura, Y. Yamamoto, N. Kudomi, Y. Maeda, T. Norikane, K. Miyake, et al., Intratumoral heterogeneity of 18f-FLT uptake predicts proliferation and survival in patients with newly diagnosed gliomas, Ann. Nucl. Med., 31 (2017), 46-52. |
[159] |
D. A. Hormuth II, J. A. Weis, S. L. Barnes, M. I. Miga, V. Quaranta, T. E. Yankeelov, Biophysical modeling of in vivo glioma response after whole-brain radiation therapy in a murine model of brain cancer, Int. J. Radiat. Oncol. Biol. Phys., 100 (2018), 1270-1279. doi: 10.1016/j.ijrobp.2017.12.004
![]() |
[160] | E. M. Rutter, T. L. Stepien, B. J. Anderies, J. D. Plasencia, E. C. Woolf, A. C. Scheck, et al., Mathematical analysis of glioma growth in a murine model, Sci. Rep., 7 (2017), 2508. |
[161] | S. Benzekry, C. Lamont, J. Weremowicz, A. Beheshti, L. Hlatky, P. Hahnfeldt, Tumor growth kinetics of subcutaneously implanted Lewis Lung carcinoma cells, 2019. Available from: https://zenodo.org/record/3572401#.Xqt0TlNKjRZ. |
[162] | M. Mastri, A. Tracz, J. M. L. Ebos, Tumor growth kinetics of human LM2-4LUC+ triple negative breast carcinoma cells, 2019. Available from: https://zenodo.org/record/3574531#.Xqtzv1NKjRZ. |
[163] | A. Rodallec, S. Giocometti, J. Ciccolini, R. Fanciullino, Tumor growth kinetics of human MDA-MB-231 cells transfected with dTomato lentivirus, 2019. Available from: https://zenodo.org/record/3593919#.Xqt0PlNKjRZ. |
1. | Muqrin A. Almuqrin, A new flexible distribution with applications to engineering data, 2023, 69, 11100168, 371, 10.1016/j.aej.2023.01.046 | |
2. | Mahdi Rasekhi, Mohammad Mehdi Saber, G. G Hamedani, M. M.Abd El-Raouf, Ramy Aldallal, Ahmed M. Gemeay, Melike Kaplan, Approximate Maximum Likelihood Estimations for the Parameters of the Generalized Gudermannian Distribution and Its Characterizations, 2022, 2022, 2314-4785, 1, 10.1155/2022/4092576 | |
3. | Yinghui Zhou, Zubair Ahmad, Zahra Almaspoor, Faridoon Khan, Elsayed tag-Eldin, Zahoor Iqbal, Mahmoud El-Morshedy, On the implementation of a new version of the Weibull distribution and machine learning approach to model the COVID-19 data, 2022, 20, 1551-0018, 337, 10.3934/mbe.2023016 | |
4. | Abdulaziz S. Alghamdi, M. M. Abd El-Raouf, A New Alpha Power Cosine-Weibull Model with Applications to Hydrological and Engineering Data, 2023, 11, 2227-7390, 673, 10.3390/math11030673 | |
5. | Najwan Alsadat, Aijaz Ahmad, Muzamil Jallal, Ahmed M. Gemeay, Mohammed A. Meraou, Eslam Hussam, Ehab M.Elmetwally, Md. Moyazzem Hossain, The novel Kumaraswamy power Frechet distribution with data analysis related to diverse scientific areas, 2023, 70, 11100168, 651, 10.1016/j.aej.2023.03.003 | |
6. | Najwan Alsadat, A new modified model with application to engineering data sets, 2023, 72, 11100168, 1, 10.1016/j.aej.2023.03.050 | |
7. | Xiangming Tang, Jin-Taek Seong, Randa Alharbi, Aned Al Mutairi, Said G. Nasr, A new probabilistic model: Theory, simulation and applications to sports and failure times data, 2024, 10, 24058440, e25651, 10.1016/j.heliyon.2024.e25651 | |
8. | Ibrahim Alkhairy, A new approach of generalized Rayleigh distribution with analysis of asymmetric data sets, 2024, 100, 11100168, 1, 10.1016/j.aej.2024.04.070 | |
9. | Shahid Mohammad, Isabel Mendoza, A New Hyperbolic Tangent Family of Distributions: Properties and Applications, 2024, 2198-5804, 10.1007/s40745-024-00516-5 | |
10. | Amulya Kumar Mahto, Yogesh Mani Tripathi, Sanku Dey, M.M. Abd El-Raouf, Najwan Alsadat, Efficient estimation of the density and distribution functions of Weibull-Burr XII distribution, 2024, 104, 11100168, 576, 10.1016/j.aej.2024.07.118 | |
11. | Faridoon Khan, Zubair Ahmad, Saima K. Khosa, Mohammed Ahmed Alomair, Abdullah Mohammed Alomair, Abdulaziz khalid Alsharidi, A new modification of the flexible Weibull distribution based on power transformation: Monte Carlo simulation and applications, 2023, 9, 24058440, e17238, 10.1016/j.heliyon.2023.e17238 | |
12. | Laxmi Prasad Sapkota, Vijay Kumar, Ahmed M. Gemeay, M. E. Bakr, Oluwafemi Samson Balogun, Abdisalam Hassan Muse, New Lomax-G family of distributions: Statistical properties and applications, 2023, 13, 2158-3226, 10.1063/5.0171949 | |
13. | Xiaochun Liu, Jian Ji, Afaf Alrashidi, Fatimah A. Almulhim, Etaf Alshawarbeh, Jin-Taek Seong, A new probabilistic model with mixed-state failure rates: Modeling time-to-event scenarios in reliability and music engineering, 2024, 96, 11100168, 99, 10.1016/j.aej.2024.03.103 | |
14. | M.M. Abd El-Raouf, Mohammed AbaOud, A novel extension of generalized Rayleigh model with engineering applications, 2023, 73, 11100168, 269, 10.1016/j.aej.2023.04.063 | |
15. | Aijaz Ahmad, Najwan Alsadat, Mintodê Nicodème Atchadé, S. Qurat ul Ain, Ahmed M. Gemeay, Mohammed Amine Meraou, Ehab M. Almetwally, Md. Moyazzem Hossain, Eslam Hussam, New hyperbolic sine-generator with an example of Rayleigh distribution: Simulation and data analysis in industry, 2023, 73, 11100168, 415, 10.1016/j.aej.2023.04.048 | |
16. | Zubir Shah, Ehab M. Almetwally, Dost Muhammad Khan, Farrukh Jamal, A novel odd Type-X family of distributions: Model, theory, and applications to medical, insurance, and engineering data sets, 2025, 18, 16878507, 101451, 10.1016/j.jrras.2025.101451 | |
17. | Suleman Nasiru, Christophe Chesneau, Selasi Kwaku Ocloo, Abdul Ghaniyyu Abubakari, The Log-Cosine-Power Generated Family of Distributions, 2025, 2730-9657, 10.1007/s44007-025-00162-0 | |
18. | Badr Aloraini, Improved estimation of population parameter of in the existence of nonresponse using auxiliary information, 2025, 10, 2473-6988, 12312, 10.3934/math.2025558 |
Parameter | Description | Estimated value | Source |
δ | Constant recruitment rate of the population | 0.8day−1 | [14] |
β | Transmission coefficient of TB | 0.0099-0.8person−1day−1 | Estimate |
α | The coefficient that determines how effective TB | 0.00091-0.8day−1 | [14] |
information can influence the transmission rate | |||
μ | Nature death rate | 0.009-0.6year−1 | Estimate |
q | The proportion of disease by fast progression | 0-0.5year−1 | Estimate |
ε | The progression rate from E to I | 0.02-0.99day−1 | Estimate |
d | The disease-related death rate of TB | 0.002-0.5day−1 | Estimate |
γ | The recovery rate of TB | 0.006-0.99day−1 | Estimate |
μ1 | The rate that susceptible individuals may send | 0.04-0.99day−1 | [26] |
message about TB | |||
μ2 | The rate that exposed individuals may send | 0.008-0.8day−1 | [26] |
message about TB | |||
μ3 | The rate that infectious individuals may send | 0.08-0.8day−1 | [26] |
message about TB | |||
μ4 | The rate that recovered individuals may send | 0-1day−1 | Estimate |
message about TB | |||
τ | The rate that message become outdated | 0.03-0.6year−1 | [26] |
Parameter | Description | Estimated value | Source |
δ | Constant recruitment rate of the population | 0.8day−1 | [14] |
β | Transmission coefficient of TB | 0.0099-0.8person−1day−1 | Estimate |
α | The coefficient that determines how effective TB | 0.00091-0.8day−1 | [14] |
information can influence the transmission rate | |||
μ | Nature death rate | 0.009-0.6year−1 | Estimate |
q | The proportion of disease by fast progression | 0-0.5year−1 | Estimate |
ε | The progression rate from E to I | 0.02-0.99day−1 | Estimate |
d | The disease-related death rate of TB | 0.002-0.5day−1 | Estimate |
γ | The recovery rate of TB | 0.006-0.99day−1 | Estimate |
μ1 | The rate that susceptible individuals may send | 0.04-0.99day−1 | [26] |
message about TB | |||
μ2 | The rate that exposed individuals may send | 0.008-0.8day−1 | [26] |
message about TB | |||
μ3 | The rate that infectious individuals may send | 0.08-0.8day−1 | [26] |
message about TB | |||
μ4 | The rate that recovered individuals may send | 0-1day−1 | Estimate |
message about TB | |||
τ | The rate that message become outdated | 0.03-0.6year−1 | [26] |